•  
  •  
  •  
  •  

2026-07-24 15:47:04

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Shriram Finance Delivers Strong Q1 FY27 Results: Consolidated Net Profit Surges 60% YoY to ₹3,453 Crore; AUM Reaches ₹3.14 Lakh Crore
  • ZF Commercial Vehicle Control Systems India Reports Q1 FY27 Revenue Up 9% YoY to ₹1,066 Crore; Net Profit Stands at ₹104.5 Crore
  • Ponni Sugars (Erode) Reports Q1 FY27 Results: Operational Turnaround Reduces Net Losses to ₹1.23 Crore as Revenue Surges 52% YoY
  • Dolphin Offshore Enterprises Reports 31% Rise in Q1 FY27 Net Profit to ₹14.81 Crore; Revenue Surges 161% YoY to ₹42.85 Crore
  • Dr. Lal PathLabs Reports Strong Q1 FY27 Performance with Net Profit Rising 27% YoY to ₹1,705 Million; Revenue Up 19%

Keywords Selected:  SequentScientific

Stock Report

  • Viyash Scientific further strengthens European Companion Animal Presence with acquisition of Italy's BioForLife
  • SeQuent Scientific and Viyash Lifesciences Receive NCLT Approval for Transformational Merger
  • Sequent Scientific Limited Receives WHO Prequalification Approval for Albendazole API
  • Sequent Scientific Ltd updates on land sale
  • Sequent Scientific Ltd gets Form 483 with One Observation from USFDA for Vizag facility
  • Sequent Scientific Ltd discontinues operations at Tarapur unit
  • Sequent Scientific Ltd Q4 FY2023 consolidated loss widens to Rs. 93.57 crores
  • SeQuent Scientific to acquire 100% stake in Tineta Pharma to scale up India Animal Health business
  • Sequent Scientific Ltd posts Rs. 3.75 crores consolidated loss in Q2FY23
  • Sequent Scientific Ltd Q1 FY2023 consolidated loss at Rs. 14.05 crores
  • Sequent Scientific Ltd Q4FY22 consolidated PAT falls to Rs. 8.96 crores
  • Fire incident at Sequent Scientific Ltd subsidiary's Unit at Ramky Pharma City SEZ JNPC, Visakhapatnam
  • Sequent Scientific Limited announces resignation of Chief Financial Officer
  • Sequent Scientific completes entry into pet segment in Brazil
  • Sequent Scientific posts Rs. 17.11 crores consolidated profit in Q3 FY22
  • SeQuent Scientific appoints Rajaram Narayanan as Managing Director and CEO
  • Sequent Scientific consolidates residual stake in Evance Group, Brazil
  • Sequent Scientific forays into pet segment in Brazil
  • Sequent Scientific Ltd reports Rs. 14.30 crore consolidated PAT in Q2FY22

Latest Post

  • Shriram Finance Delivers Strong Q1 FY27 Results: Consolidated Net Profit Surges 60% YoY to ₹3,453 Crore; AUM Reaches ₹3.14 Lakh Crore
  • ZF Commercial Vehicle Control Systems India Reports Q1 FY27 Revenue Up 9% YoY to ₹1,066 Crore; Net Profit Stands at ₹104.5 Crore
  • Ponni Sugars (Erode) Reports Q1 FY27 Results: Operational Turnaround Reduces Net Losses to ₹1.23 Crore as Revenue Surges 52% YoY
  • Dolphin Offshore Enterprises Reports 31% Rise in Q1 FY27 Net Profit to ₹14.81 Crore; Revenue Surges 161% YoY to ₹42.85 Crore
  • Dr. Lal PathLabs Reports Strong Q1 FY27 Performance with Net Profit Rising 27% YoY to ₹1,705 Million; Revenue Up 19%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025